Loading...

Inventiva S.A.

IVANASDAQ
Healthcare
Biotechnology
$4.97
$-0.16(-3.12%)
U.S. Market opens in 5h 2m

Inventiva S.A. Fundamental Analysis

Inventiva S.A. (IVA) shows moderate financial fundamentals with a PE ratio of -7.78, profit margin of -78.71%, and ROE of 18.38%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.36
Current Ratio3.15

Areas of Concern

Operating Margin-29.21%
Cash Position3.12%
We analyze IVA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -7292.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-7292.9/100

We analyze IVA's fundamental strength across five key dimensions:

Efficiency Score

Weak

IVA struggles to generate sufficient returns from assets.

ROA > 10%
-1.42%

Valuation Score

Excellent

IVA trades at attractive valuation levels.

PE < 25
-7.78
PEG Ratio < 2
-0.36

Growth Score

Weak

IVA faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IVA maintains a strong and stable balance sheet.

Debt/Equity < 1
-2.05
Current Ratio > 1
3.15

Profitability Score

Weak

IVA struggles to sustain strong margins.

ROE > 15%
18.38%
Net Margin ≥ 15%
-78.71%
Positive Free Cash Flow
No

Key Financial Metrics

Is IVA Expensive or Cheap?

P/E Ratio

IVA trades at -7.78 times earnings. This suggests potential undervaluation.

-7.78

PEG Ratio

When adjusting for growth, IVA's PEG of -0.36 indicates potential undervaluation.

-0.36

Price to Book

The market values Inventiva S.A. at -94.48 times its book value. This may indicate undervaluation.

-94.48

EV/EBITDA

Enterprise value stands at -1.08 times EBITDA. This is generally considered low.

-1.08

How Well Does IVA Make Money?

Net Profit Margin

For every $100 in sales, Inventiva S.A. keeps $-78.71 as profit after all expenses.

-78.71%

Operating Margin

Core operations generate -29.21 in profit for every $100 in revenue, before interest and taxes.

-29.21%

ROE

Management delivers $18.38 in profit for every $100 of shareholder equity.

18.38%

ROA

Inventiva S.A. generates $-1.42 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.42%

Following the Money - Real Cash Generation

Operating Cash Flow

Inventiva S.A. generates limited operating cash flow of $-8.82M, signaling weaker underlying cash strength.

$-8.82M

Free Cash Flow

Inventiva S.A. generates weak or negative free cash flow of $-8.84M, restricting financial flexibility.

$-8.84M

FCF Per Share

Each share generates $-0.17 in free cash annually.

$-0.17

FCF Yield

IVA converts -48.70% of its market value into free cash.

-48.70%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-7.78

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.36

vs 25 benchmark

P/B Ratio

Price to book value ratio

-94.48

vs 25 benchmark

P/S Ratio

Price to sales ratio

49.93

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-2.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

18.38

vs 25 benchmark

ROA

Return on assets percentage

-1.42

vs 25 benchmark

ROCE

Return on capital employed

-0.76

vs 25 benchmark

How IVA Stacks Against Its Sector Peers

MetricIVA ValueSector AveragePerformance
P/E Ratio-7.7829.29 Better (Cheaper)
ROE1838.48%690.00% Excellent
Net Margin-7870.52%-45102.00% (disorted) Weak
Debt/Equity-2.050.43 Strong (Low Leverage)
Current Ratio3.154.48 Strong Liquidity
ROA-141.76%-14932.00% (disorted) Weak

IVA outperforms its industry in 4 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Inventiva S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ